Cross-sectional study of the impact of disability status on prostate cancer screening among US men aged 55 to 69 years

People with disabilities experience persistent inequities in preventive care, yet contemporary data on PSA testing disparities are limited. A cross-sectional study using 2023 data from the Behavioral Risk Factor Surveillance System (BRFSS; a US population-based telephone survey) evaluated the association between disability status and self-reported PSA testing amon US men aged 55 to 69 years. In this study including a weighted sample of 5 058 866 men, 29.6% reported at least one disability. Overall, 62.7% reported prior PSA testing, with lower testing among men with disabilities (57.2%; 95% CI 54.2-60.2) than among men without disabilities (65.1%; 63.2-67.0). In adjustede survey-weighted models, disability was associated with lower odds of PSA testing (aOR 0.83; 95% CI 0.69-0.96). Among disability types, mobility disability was associated with lower testing. The authors conclude that these findings suggest that substantial disparities in prostate cancer screening exist for men with disabilities, and targeted interventions are needed to improve equitable access to preventive care.